These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 6349797)

  • 21. Variability in surface antigen expression of human breast epithelial cells cultured from normal breast, normal tissue peripheral to breast carcinomas, and breast carcinomas.
    Ceriani RL; Peterson JA; Blank EW
    Cancer Res; 1984 Jul; 44(7):3033-9. PubMed ID: 6144385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of normal and tumor-associated antigens in human breast carcinoma.
    Sawtell NM; DiPersio L; Michael JG; Pesce AJ; Weiss MA
    Lab Invest; 1984 Aug; 51(2):225-32. PubMed ID: 6087025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A human breast tissue-associated antigen detected by a monoclonal antibody.
    Thompson CH; Jones SL; Whitehead RH; McKenzie IF
    J Natl Cancer Inst; 1983 Mar; 70(3):409-19. PubMed ID: 6187962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical localization of prostate carcinoma-associated antigens.
    Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
    Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue distribution, immunochemical characterization, and biosynthesis of 47D10, a tumor-associated surface glycoprotein.
    Ho MK; Kato KP; Durda PJ; Murray JH; Wolfe H; Rabin H; Carney WP
    Cancer Res; 1987 Jan; 47(1):241-50. PubMed ID: 3539319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reactivity of monoclonal antibody 17.13. with human squamous cell carcinoma and its application to tumor diagnosis.
    Ranken R; White CF; Gottfried TG; Yonkovich SJ; Blazek BE; Moss MS; Fee WE; Liu YS
    Cancer Res; 1987 Nov; 47(21):5684-90. PubMed ID: 3311357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunocytochemical reactivity of a mouse monoclonal antibody CDI 315B raised against human breast carcinoma.
    Beketić-Oresković L; Sarcević B; Malenica B; Novak D
    Neoplasma; 1993; 40(2):69-74. PubMed ID: 8394515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of multiple, repeated doses of radioimmunotherapy on target antigen expression (breast MUC-1 mucin) in breast carcinomas.
    Peterson JA; Blank EW; Ceriani RL
    Cancer Res; 1997 Mar; 57(6):1103-8. PubMed ID: 9067279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical reactivity of anti-melanoma monoclonal antibody 225.28S in human breast cancer biopsies.
    Dell'Erba L; Calo-Gabrieli G; Caruso ML; Thomas R; Cortino G; Valentini AM; Muto P; Albrizio M; Pastena MI; Lastoria S
    Anticancer Res; 2001; 21(2A):925-30. PubMed ID: 11396186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammary cancer antigen recognized by monoclonal antibody B72.3 in apocrine metaplasia of the human breast.
    Castagna M; Nuti M; Squartini F
    Cancer Res; 1987 Feb; 47(3):902-6. PubMed ID: 3542197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection of tumor antigens as targets for immune attack using immunohistochemistry: protein antigens.
    Zhang S; Zhang HS; Cordon-Cardo C; Ragupathi G; Livingston PO
    Clin Cancer Res; 1998 Nov; 4(11):2669-76. PubMed ID: 9829729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen regulation of H59 antigen in vivo and in vitro.
    Hendler FJ; Patrick K; House D
    Prog Clin Biol Res; 1986; 204():105-23. PubMed ID: 3960864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the specificity by immunohistology of a monoclonal antibody to a novel epithelial antigen of ovarian carcinomas.
    Mariani-Costantini R; Agresti R; Colnaghi MI; Ménard S; Andreola S; Rilke F
    Pathol Res Pract; 1985 Aug; 180(2):169-80. PubMed ID: 3903701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a cell-surface antigen (LEA.135) associated with favorable prognosis in human breast cancer.
    Imam SA; Esteban EF; Chen RS; Cardiff RD; Taylor CR
    Cancer Res; 1993 Jul; 53(14):3233-6. PubMed ID: 7686814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphologic assessment of reactivity to monoclonal antibodies generated against breast cancer cells in mammary tissues removed for clinical dysplasia or cancer.
    Nuti M; Castagna M; Squartini F
    Appl Pathol; 1984; 2(3):117-27. PubMed ID: 6085790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two monoclonal antibodies selective for human mammary carcinoma.
    White CA; Dulbecco R; Allen R; Bowman M; Armstrong B
    Cancer Res; 1985 Mar; 45(3):1337-43. PubMed ID: 3971377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of epithelial marker expression in routinely processed, poorly differentiated carcinomas.
    Kamel OW; Rouse RV; Warnke RA
    Arch Pathol Lab Med; 1991 Jun; 115(6):566-70. PubMed ID: 1710100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies against a component related to soluble estrogen receptor.
    Coffer AI; Lewis KM; Brockas AJ; King RJ
    Cancer Res; 1985 Aug; 45(8):3686-93. PubMed ID: 4016746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens.
    Hand PH; Nuti M; Colcher D; Schlom J
    Cancer Res; 1983 Feb; 43(2):728-35. PubMed ID: 6848188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.